Showing 341-350 of 8443 results for "".
New Treatment Algorithms for Actinic Keratoses
https://practicaldermatology.com/topics/skin-cancer-photoprotection/new-treatment-algorithms-for-actinic-keratoses/18812/Gary Goldenberg, MD reviews the literature showing why all actinic keratoses (AKs) need to be treated and why it's important to treat the field and not just the visible lesions. He shares his evidence-based, time-sequential therapy approach to combining a destructive modality with field therapy to pAdvances in Devices for Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/advances-in-devices-for-dermatology/18815/M. Christine Lee, MD provides an overview of some of the new and emerging laser technologies. She discusses advances in everything from lasers and light-based devices to radiofrequency, ultrasound, and combination devices for a variety of dermatologic issues including facial rejuvenation, vaginal reThe Evolving Paradigm in Treatment of Psoriasis
https://practicaldermatology.com/topics/psoriasis/the-evolving-paradigm-in-treatment-of-psoriasis/18640/Bruce Strober, MD, reviews the latest science in the management of psoriasis. Treatment strategies on the horizon may offer significantly improved efficacy with attractive dosing schedules, adding to the ability to help patients manage difficult skin and systemic implications of psoriasis, he said.The Art of Medicine in the Age of Technology
https://practicaldermatology.com/topics/practice-management/the-art-of-medicine-in-the-age-of-technology/21065/Although electronic technology offers potential for a more efficient delivery of healthcare, the patient experience may suffer as a result.Advances in Reconstructive Surgery
https://practicaldermatology.com/topics/skin-cancer-photoprotection/advances-in-reconstructive-surgery/18675/Murad Alam, MD, talks to DermTube Journal Club Host Joshua Zeichner, MD about what's new in reconstructive surgery. Dr. Alam discusses advances in fastening and adhesives to minimize scars, as well as the benefits of lasers, energy-based devices, and ultrasound to smooth scars, further minimizing thValeant Business Update; Melanoma Drugs Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-valeant-business-update-melanoma-drugs-approved/18679/In this edition of DermWireTV from the editors of Practical Dermatology® magazine and DermWire.com, we take a look at Valeant's warning of disruption of dermatology business following its break from specialty pharmacy Philidor. Plus, an update on Melanoma Therapeutics, including approvals of ImlygicSummer AAD Highlights, Alopecia Areata Discovery
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-summer-aad-highlights-alopecia-areata-discovery/18846/In this edition of DermWireTV from the editors of Practical Dermatology® magazine and DermWire.com, new research that suggests emerging biologic therapies could help treat alopecia areata. Plus, updates on atopic dermatitis and eczema, hands-on education, and Kybella from the AAD Summer meeting. AndAging: The Cornerstone of Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aging-the-cornerstone-of-dermatology/18865/In this edition of Derm Insider, Joseph Jorizzo, MD, Brooke Jackson, MD, and Adam Friedman, MD sit down with host Neal Bhatia, MD to discuss the phenomenon of aging and the ubiquitous role it plays in both the scientific and clinical practice of dermatology. In particular they reflect on the evolutiViewpoints: A New Roadmap in Eczema Care
https://practicaldermatology.com/topics/practice-management/viewpoints-a-new-roadmap-in-eczema-care/21144/New strategies in clinical care and advocacy will be essential in this emerging era of eczema management.Cosentyx Approved, Silver is Bad for Burns
https://practicaldermatology.com/topics/psoriasis/dermwiretv-cosentyx-approved-silver-is-bad-for-burns/18971/FDA approves the first IL-17 inhibitor for psoriasis—Cosentyx from Noavartis, and new research explains why silver sulfadiazine is bad for burn wounds. Plus, we get an update on the Dermatology Summit and the state of innovation in dermatology, and learn about Phase III trials for Dermira's Cimzia.